Literature DB >> 22347518

Epithelial-mesenchymal transition in cervical carcinoma.

Mei-Yi Lee, Meng-Ru Shen.   

Abstract

During the progression of epithelial cancer, cells usually lose epithelial characteristic features and gain a mesenchymal phenotype. Cervical cancer is a common female malignancy worldwide. Despite the generally good prognosis for early-stage cervical cancer patients, many patients still die as a result of metastasis and recurrence. Epithelial-mesenchymal transition (EMT) has been implicated in the metastasis of primary tumors and provides molecular mechanisms for cervical cancer metastasis. Here we provide an up-to-date overview regarding the program of EMT in cervical cancer. In the stepwise progression of cervical cancer, human papilloma viral proteins contribute to the cell transformation and the conversion of typical epithelial cells to the epithelial carcinoma cells with hybrid epithelial and mesenchymal characteristics. Molecules related to the EMT program of cervical cancer cells are summarized in this review paper. Several soluble factors acting on their cognate receptors stimulate the mesenchymal transition of cervical epithelial cells. Ion transport system as well as cytoskeletal modulators also stimulate the progression of EMT program in cervical carcinoma cells. Transcriptional factors such as Snail, Twist1, Twist2, and six1 homeoproteins are involved in the complicated regulation and cervical cancer metastasis. Among the various signalings associated with EMT program, Snail is a central transcription factor which governs EMT program. In contrast to tumor promoters, several tumor suppressors such as SFRP1/2 and LMX-1A have been reported to suppress tumorigenesis as well as metastatic spread through inhibiting the EMT program.

Entities:  

Keywords:  Epithelial-mesenchymal transition; cervical cancer; growth factors; transcriptional factors

Year:  2012        PMID: 22347518      PMCID: PMC3276374     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  69 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors.

Authors:  José-Manuel Mingot; Sonia Vega; Beatriz Maestro; Jesús M Sanz; M Angela Nieto
Journal:  J Cell Sci       Date:  2009-05-01       Impact factor: 5.285

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions.

Authors:  Zhibo Yang; Suresh Rayala; Diep Nguyen; Ratna K Vadlamudi; Shiuan Chen; Rakesh Kumar
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

6.  Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail.

Authors:  Cheng Du; Chuanyou Zhang; Sazzad Hassan; Md Helal Uddin Biswas; K C Balaji
Journal:  Cancer Res       Date:  2010-10-12       Impact factor: 12.701

7.  SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.

Authors:  Ming-Tzeung Chung; Hung-Cheng Lai; Huey-Kang Sytwu; Ming-De Yan; Yu-Lueng Shih; Cheng-Chang Chang; Mu-Hsien Yu; Hang-Seng Liu; Da-Wei Chu; Ya-Wen Lin
Journal:  Gynecol Oncol       Date:  2008-12-18       Impact factor: 5.482

8.  Zinc-finger transcription factor snail accelerates survival, migration and expression of matrix metalloproteinase-2 in human bone mesenchymal stem cells.

Authors:  Yun-hong Zha; Jie-feng He; Yuan-wu Mei; Tao Yin; Ling Mao
Journal:  Cell Biol Int       Date:  2007-03-28       Impact factor: 3.612

9.  Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.

Authors:  K Syrjänen; V Kataja; M Yliskoski; F Chang; S Syrjänen; S Saarikoski
Journal:  Obstet Gynecol       Date:  1992-05       Impact factor: 7.661

10.  Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression.

Authors:  S Srivastava; B Ramdass; S Nagarajan; M Rehman; G Mukherjee; S Krishna
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more
  55 in total

1.  Quantitative Mass Spectrometry Reveals Changes in Histone H2B Variants as Cells Undergo Inorganic Arsenic-Mediated Cellular Transformation.

Authors:  Matthew Rea; Tingting Jiang; Rebekah Eleazer; Meredith Eckstein; Alan G Marshall; Yvonne N Fondufe-Mittendorf
Journal:  Mol Cell Proteomics       Date:  2016-05-11       Impact factor: 5.911

2.  14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein.

Authors:  Kumarkrishna Raychaudhuri; Neelam Chaudhary; Mansa Gurjar; Roseline D'Souza; Jazeel Limzerwala; Subbareddy Maddika; Sorab N Dalal
Journal:  J Biol Chem       Date:  2016-06-03       Impact factor: 5.157

3.  Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma.

Authors:  Zhi-Li Zhao; Si-Rui Ma; Wei-Ming Wang; Cong-Fa Huang; Guang-Tao Yu; Tian-Fu Wu; Lin-Lin Bu; Yu-Fan Wang; Yi-Fang Zhao; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

4.  URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin.

Authors:  Junxia Gu; Yuting Liang; Longwei Qiao; Yaojuan Lu; Xiaoxia Hu; Dongwei Luo; Na Li; Leilei Zhang; Yiyang Chen; Jialu Du; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

5.  Expression and prognostic significance of TAp73 and ΔNp73 in FIGO stage I-II cervical squamous cell carcinoma.

Authors:  Weipei Zhu; Xiaohong Pan; Zhujuan Yang; Pengfei Xing; Yongshen Zhang; Feng Li; Xueguan Lu
Journal:  Oncol Lett       Date:  2015-03-17       Impact factor: 2.967

6.  MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition.

Authors:  Xiaomei Wu; Xiaowei Xi; Qin Yan; Zhenbo Zhang; Bin Cai; Wen Lu; Xiaoping Wan
Journal:  Med Oncol       Date:  2013-10-26       Impact factor: 3.064

7.  ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.

Authors:  Weidong Zhao; Huiyan Wang; Xiaohui Han; Jie Ma; Yuanyuan Zhou; Zhengzheng Chen; Hu Zhou; Hanjie Xu; Zhengwei Sun; Beihua Kong; Huiying Fang
Journal:  Tumour Biol       Date:  2016-02-10

8.  ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.

Authors:  Yihui Ma; Xiangyu Zheng; Jun Zhou; Ying Zhang; Kuisheng Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.

Authors:  Yan Qi; Cui-Cui Wang; Yong-Lai He; Hong Zou; Chun-Xia Liu; Li-Juan Pang; Jian-Ming Hu; Jin-Fang Jiang; Wen-Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

10.  Akt-mediated transforming growth factor-β1-induced epithelial-mesenchymal transition in cultured human esophageal squamous cancer cells.

Authors:  X Xuan; Q Zeng; Y Li; Y Gao; F Wang; H Zhang; Z Wang; H He; S Li
Journal:  Cancer Gene Ther       Date:  2014-05-30       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.